Jundishapur Journal of Microbiology

Published by: Kowsar

Emergence of Extensively Drug Resistant Acinetobacter baumannii-Encoding Integrons and Extended-Spectrum Beta-Lactamase Genes Isolated from Ventilator-Associated Pneumonia Patients

Mohammad Sadegh Rezai 1 , Alireza Rafiei 2 , Fatemeh Ahangarkani 3 , Masoumeh Bagheri-Nesami 1 , * , Attieh Nikkhah 1 , Khaironesa Shafahi 4 , Gohar Eslami 5 , Azin Hajalibeig 1 and Rezvan Khajavi 2
Authors Information
1 Infectious Diseases Research Center with Focus on Nosocomial Infection, Mazandaran University of Medical Sciences, Sari, Iran
2 Molecular and Cell Biology Research Center, Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
3 Antimicrobial Resistance Research Center, Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
4 Fatemeh Zahra Hospital, Mazandaran University of Medical Sciences, Sari, Iran
5 Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
Article information
  • Jundishapur Journal of Microbiology: July 2017, 10 (7); e14377
  • Published Online: June 18, 2017
  • Article Type: Research Article
  • Received: November 30, 2016
  • Revised: May 3, 2017
  • Accepted: May 8, 2017
  • DOI: 10.5812/jjm.14377

To Cite: Rezai M S, Rafiei A, Ahangarkani F, Bagheri-Nesami M, Nikkhah A, et al. Emergence of Extensively Drug Resistant Acinetobacter baumannii-Encoding Integrons and Extended-Spectrum Beta-Lactamase Genes Isolated from Ventilator-Associated Pneumonia Patients, Jundishapur J Microbiol. 2017 ; 10(7):e14377. doi: 10.5812/jjm.14377.

Copyright © 2017, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Chaari A, Mnif B, Bahloul M, Mahjoubi F, Chtara K, Turki O, et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors. Int J Infect Dis. 2013; 17(12)-8[DOI][PubMed]
  • 2. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008; 29(11): 996-1011[DOI][PubMed]
  • 3. Hartzell JD, Kim AS, Kortepeter MG, Moran KA. Acinetobacter pneumonia: a review. MedGenMed. 2007; 9(3): 4[PubMed]
  • 4. Lin CY, Chen YM, Lin MC, Chang YP, Chao TY, Wang CC, et al. Risk factors of multidrug-resistant Acinetobacter baumannii recurrence after successful eradication in ventilated patients. Biomed J. 2016; 39(2): 130-8[DOI][PubMed]
  • 5. Aliakbarzade K, Farajnia S, Karimi Nik A, Zarei F, Tanomand A. Prevalence of Aminoglycoside Resistance Genes in Acinetobacter baumannii Isolates. Jundishapur J Microbiol. 2014; 7(10)[DOI][PubMed]
  • 6. Kempf M, Rolain JM. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents. 2012; 39(2): 105-14[DOI][PubMed]
  • 7. Grgurich PE, Hudcova J, Lei Y, Sarwar A, Craven DE. Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens. Expert Rev Respir Med. 2012; 6(5): 533-55[DOI][PubMed]
  • 8. Scott P, Deye G, Srinivasan A, Murray C, Moran K, Hulten E, et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis. 2007; 44(12): 1577-84[DOI][PubMed]
  • 9. Lei J, Han S, Wu W, Wang X, Xu J, Han L. Extensively drug-resistant Acinetobacter baumannii outbreak cross-transmitted in an intensive care unit and respiratory intensive care unit. Am J Infect Control. 2016; 44(11): 1280-4[DOI][PubMed]
  • 10. Poirel L, Bonnin RA, Nordmann P. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species. IUBMB Life. 2011; 63(12): 1061-7[DOI][PubMed]
  • 11. Huang LY, Lu PL, Chen TL, Chang FY, Fung CP, Siu LK. Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan. Antimicrob Agents Chemother. 2010; 54(6): 2699-703[DOI][PubMed]
  • 12. Farajnia S, Azhari F, Alikhani MY, Hosseini MK, Peymani A, Sohrabi N. Prevalence of PER and VEB Type Extended Spectrum Betalactamases among Multidrug Resistant Acinetobacter baumannii Isolates in North-West of Iran. Iran J Basic Med Sci. 2013; 16(6): 751-5[PubMed]
  • 13. Bagheri-Nesami M, Rafiei A, Eslami G, Ahangarkani F, Rezai MS, Nikkhah A, et al. Assessment of extended-spectrum beta-lactamases and integrons among Enterobacteriaceae in device-associated infections: multicenter study in north of Iran. Antimicrob Resist Infect Control. 2016; 5: 52[DOI][PubMed]
  • 14. Collee J, Miles R, Watt B. Practical medical microbiology. 1996; : 131-50
  • 15. Koneman EW, Allen SD, Janda WM, Schreckenberger R, Winn WC. Color atlasand textbook of diagnostic microbiology. 1997; : 121-70
  • 16. ClSI . Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. M100-S23. 2013;
  • 17. Manchanda V, Sanchaita S, Singh N. Multidrug resistant acinetobacter. J Glob Infect Dis. 2010; 2(3): 291-304[DOI][PubMed]
  • 18. Rezai MS, Pourmousa R, Dadashzadeh R, Ahangarkani F. Multidrug resistance pattern of bacterial agents isolated from patient with chronic sinusitis. Caspian J Intern Med. 2016; 7(2): 114-9[PubMed]
  • 19. Sidjabat HE, Paterson DL, Adams-Haduch JM, Ewan L, Pasculle AW, Muto CA, et al. Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob Agents Chemother. 2009; 53(11): 4733-9[DOI][PubMed]
  • 20. Naas T, Bogaerts P, Bauraing C, Degheldre Y, Glupczynski Y, Nordmann P. Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium. J Antimicrob Chemother. 2006; 58(1): 178-82[DOI][PubMed]
  • 21. Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother. 2008; 52(8): 2818-24[DOI][PubMed]
  • 22. Weldhagen GF, Poirel L, Nordmann P. Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother. 2003; 47(8): 2385-92[DOI][PubMed]
  • 23. Chen CH, Huang CC. Risk factor analysis for extended-spectrum beta-lactamase-producing Enterobacter cloacae bloodstream infections in central Taiwan. BMC Infect Dis. 2013; 13: 417[DOI][PubMed]
  • 24. Correa FE, Dantas FG, Grisolia AB, Crispim Bdo A, Oliveira KM. Identification of class 1 and 2 integrons from clinical and environmental Salmonella isolates. J Infect Dev Ctries. 2014; 8(12): 1518-24[DOI][PubMed]
  • 25. Turton JF, Kaufmann ME, Warner M, Coelho J, Dijkshoorn L, van der Reijden T, et al. A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect. 2004; 58(3): 170-9[DOI][PubMed]
  • 26. Landman D, Quale JM, Mayorga D, Adedeji A, Vangala K, Ravishankar J, et al. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med. 2002; 162(13): 1515-20[DOI][PubMed]
  • 27. van den Broek PJ, Arends J, Bernards AT, De Brauwer E, Mascini EM, van der Reijden TJ, et al. Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001. Clin Microbiol Infect. 2006; 12(9): 837-43[DOI][PubMed]
  • 28. Rahimzadeh A, Farajnia S, POURBABAEE AA, Ansarin KH, ZOLFAGHARI MR, MASOUDI N. Detection of Prevalence of OXA-2 and OXA-10 Type ESBL and Class I integron among acinetobacter bumanii strains isolated from patients of Tabriz city (Iran) by PCR technique [In Persian]. J Babol Univ Med Sci. 2012; 14(5): 56-63
  • 29. Kempf I, Fleury MA, Drider D, Bruneau M, Sanders P, Chauvin C, et al. What do we know about resistance to colistin in Enterobacteriaceae in avian and pig production in Europe? Int J Antimicrob Agents. 2013; 42(5): 379-83[DOI][PubMed]
  • 30. Napier BA, Burd EM, Satola SW, Cagle SM, Ray SM, McGann P, et al. Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii. MBio. 2013; 4(3)-13[DOI][PubMed]
  • 31. Prim N, Rivera A, Espanol M, Mirelis B, Coll P. In Vivo Adaptive Resistance to Colistin in Escherichia coli Isolates. Clin Infect Dis. 2015; 61(10): 1628-9[DOI][PubMed]
  • 32. Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar AE, Garcia-Garmendia JL, Bernabeu-Wittel IM, et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis. 2003; 36(9): 1111-8[DOI][PubMed]
  • 33. Almasaudi SB. Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features. Saudi Biol Sci. 2016; [DOI]
  • 34. Yadav R, Landersdorfer CB, Nation RL, Boyce JD, Bulitta JB. Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2015; 59(4): 2286-98[DOI][PubMed]
  • 35. Safari M, Mozaffari Nejad AS, Bahador A, Jafari R, Alikhani MY. Prevalence of ESBL and MBL encoding genes in Acinetobacter baumannii strains isolated from patients of intensive care units (ICU). Saudi J Biol Sci. 2015; 22(4): 424-9[DOI][PubMed]
  • 36. Alyamani EJ, Khiyami MA, Booq RY, Alnafjan BM, Altammami MA, Bahwerth FS. Molecular characterization of extended-spectrum beta-lactamases (ESBLs) produced by clinical isolates of Acinetobacter baumannii in Saudi Arabia. Ann Clin Microbiol Antimicrob. 2015; 14: 38[DOI][PubMed]
  • 37. Sharif M, Mirnejad R, Amirmozafari N. Molecular identification of TEM and SHV extended spectrum beta-lactamase in clinical isolates of Acinetobacter baumannii from Tehran hospitals. J Genes Microb Immun. 2014; 2014: 1-9[DOI]
  • 38. Huang ZM, Mao PH, Chen Y, Wu L, Wu J. [Study on the molecular epidemiology of SHV type beta-lactamase-encoding genes of multiple-drug-resistant acinetobacter baumannii]. Zhonghua Liu Xing Bing Xue Za Zhi. 2004; 25(5): 425-7[PubMed]
  • 39. Hakemi Vala M, Hallajzadeh M, Hashemi A, Goudarzi H, Tarhani M, Sattarzadeh Tabrizi M, et al. Detection of Ambler class A, B and D ss-lactamases among Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates from burn patients. Ann Burns Fire Disasters. 2014; 27(1): 8-13[PubMed]
  • 40. Ahanjan M, Kholdi S, Rafiei A. Antibiotic-resistance patterns and frequency of TEM and CTX type extended-spectrum β-lactamases in acinetobacter clinical isolates [In Persian]. J Mazandaran Univ Med Sci. 2014; 24(116): 32-40
  • 41. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol. 2003; 41(8): 3542-7[DOI][PubMed]
  • 42. Pasteran F, Rapoport M, Petroni A, Faccone D, Corso A, Galas M, et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii Strains in the Americas. Antimicrob Agents Chemother. 2006; 50(9): 3222-4[DOI][PubMed]
  • 43. Fazeli H, Taraghian A, Poursina F, Kamali R. Molecular identification of Esbl Genes Bla-Shv, Bla-Veb, and Bla-Per, in acinetobacter Baumannii isolated from patients admitted in a university hospital in Isfahan. Iran J Public Health. 2014; 43(2): 39
  • 44. Behzadnia S, Davoudi A, Rezai MS, Ahangarkani F. Nosocomial infections in pediatric population and antibiotic resistance of the causative organisms in north of iran. Iran Red Crescent Med J. 2014; 16[PubMed]
  • 45. Saffar MJ, Enayti AA, Abdolla IA, Razai MS, Saffar H. Antibacterial susceptibility uropathogens in 3 hospitals, Sari, Islamic Republic of Iran, 2002-2003. East Mediterr Health J. 2018; 14(3): 556-63[PubMed]
  • 46. Eslami G, Rezaie MS, Salehifar E, Rafiei A, Langaie T, Rafati MR, et al. Epidemiology of Extended Spectrum Beta Lactamases Producing E. coli Genes in Strains Isolated from Children with Urinary Tract Infection in North of Iran. J Mazandaran Univ Med Sci. 2016; 25(132): 270-9
  • 47. Yazdani Cherati J, Shojaee J, Chaharkameh A, Rezai MS, Khosravi F, Rezai F, et al. Incidence of nosocomial infection in selected cities according NISS software in Mazandaran province. J Mazandaran Univ Med Sci. 2015; 24(122): 64-72
  • 48. Rezai MS, Bagheri-nesami M, Hajalibeig A, Ahangarkani F. Multidrug and Cross-resistance Pattern of ESBL-producing Enterobacteriaceae Agents of Nosocomial Infections in Intensive Care Units. J Mazandaran Univ Med Sci. 2017; 26(144): 39-49
  • 49. Rezai MS, Salehifar E, Rafiei A, Langaee T, Rafati M, Shafahi K, Eslami G. Characterization of multidrug resistant extended-spectrum beta-lactamase-producing Escherichia coli among uropathogens of pediatrics in North of Iran. Biomed Res Int. 2015; [DOI][PubMed]
  • 50. Eslami G, Salehifar E, Behbudi M, Rezai MS. Rational Use of Amikacin in Buali-Sina Hospital in Sari 2011. J Mazandaran Univ Med Sci. 2013; 23(100): 2-9
  • 51. Fahimzad A, Eydian Z, Karimi A, Shiva F, Sayyahfar S, Kahbazi M, et al. Surveillance of antibiotic consumption point prevalence survey 2014: Antimicrobial prescribing in pediatrics wards of 16 Iranian hospitals. Arch Iran Med. 2016; 19(3): 204-9[PubMed]
  • 52. Rezai M, Bagheri-Nesami M, Nikkhah A. Catheter-related urinary nosocomial infections in intensive care units: An epidemiologic study in North of Iran. Caspian J Intern Med. 2017; 8(2): 76-82[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments